The clinical-epidemiological characteristics and comorbidity of endoscopically positive gastroesophageal reflux disease

Vologzhanina L.G.

Academician E.A. Vagner Perm State Medical University, Ministry of Health of the Russian Federation, Perm, Russia

Authors:

Vologzhanina L.G.

More about the authors

Journal: Russian Journal of Evidence-Based Gastroenterology. 2017;6(2): 54‑58

DOI: 10.17116/dokgastro20176254-58

Downloaded: 19

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Vologzhanina LG. The clinical-epidemiological characteristics and comorbidity of endoscopically positive gastroesophageal reflux disease. Russian Journal of Evidence-Based Gastroenterology. 2017;6(2):54‑58. (In Russ.)
https://doi.org/10.17116/dokgastro20176254-58

Подписка 2025 (Russian Journal of Evidence-Based Gastroenterology)

Close metadata

This article was designed to discuss the selected clinical-epidemiological characteristics and co-morbidity of endoscopically positive gastroesophageal reflux disease (GERD) obtained during the examination of 135 patients presenting with this pathology based at 7 medical centres of the city of Perm. The questionnaire studies, the analysis of medical histories, the physical and endoscopic examination of the patients provided the materials for the verification of the diagnosis and elucidation of the possible risk factors of GERD as well as of co-morbid gastroenterological diseases. All the patients were prescribed the basal antisecretory treatment with the use of the modern proton pump inhibitor esomeprazole (Nexium). We estimated the potential advantages of the questionnaire studies for diagnostics of GERD and evaluated the effectiveness of esomeprazole (Nexium) therapy.

Keywords:

gastroesophageal reflux disease

the GerdQ questionnaire

medical history

body mass index

esomeprazole (Nexium)

Authors:

Vologzhanina L.G.

Academician E.A. Vagner Perm State Medical University, Ministry of Health of the Russian Federation, Perm, Russia

List of references:

Hirsch DP, Tytgat GN, Boeckxstaens GE. Transient lower oesophageal sphincter relaxations: Pharmacological target for gastrooesophageal reflux disease. Aliment Pharmacol Ther. 2002;1:17-26. https://doi.org/10.1046/j.1365-2036.2002.01153.x
Orlando RC. Overview of the mechanisms of gastroesophageal reflux. Amer J Med. 2001;111:174-177. https://doi.org/10.1016/S0002-9343(01)00828-2
Levitskaya NV, Shadrina ES, Dizba SK. Gastroezofageal’nyi reflyuks u detei s vegetososudistoi distoniei. Mater. 18-i vseros. nauchn. konf. s mezhdun. uchastiem «Fiziologiya i patologiya pishchevareniya». Gelendzhik; 2002. (In Russ.).
Sekareva EV. Sostoyanie vegetativnoi nervnoi sistemy u bol’nykh gastroezofageal’noi reflyuksnoi bolezn’yu. Ekperimental’naya i klinicheskaya gastroenterologiya. 2003;1:107. (In Russ.).
Maev IV, Samsonov AA, Andreev NG. Simptom izzhogi: privychnyi diskomfort ili ser’eznaya problema? Farmateka. 2011. (In Russ.).
Tsimmerman YaS, Vologzhanina LG. Kliniko-funktsional’nye osobennosti yazvennoi bolezni dvenadtsatiperstnoi kishki, protekayushchei v sochetanii s gastroezofageal’noi reflyuksnoi bolezn’yu. Gastroenterologiya Sankt-Peterburga. 2004;2-3:160-161. (In Russ.).
Friedenberg FK. The association between gastroesophageal reflux disease and obesity. Am J Gastroenterol. 2008;103(8):2111-2122. https://doi.org/10.1111/j.1572-0241.2008.01946.x
Kulig M. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease an analysis based on the ProGERD initiative. Aliment Pharmacol Ther. 2003;18(8):767-776. https://doi.org/10.1046/j.1365-2036.2003.01770.x
Moayyedi P. The epidemiology of obesity and gastrointestinal and other diseases: an overview. Dig Dis Sci. 2008;53(9):2293-2299. https://doi.org/10.1007/s10620-008-0410-z
Cai N. Association between body mass index and erosive esophagitis: a meta-analysis. World J Gastroenterol. 2012;18(20): 2545-2553. https://doi.org/10.3748/wjg.v18.i20.2545
Sonnenberg A. Effects of environment and lifestyle on gastroesophageal reflux disease. Dig Dis. 2011;29(2):229-234. https://doi.org/10.1159/000323927
Vasilenko VKh, Grebnev AL, Sal’man MM. Bolezni pishchevoda. Meditsina; 1971. (In Russ.).
Ruigomez A, Garcia Rodriguez LA, Wallander MA et al. Natural history of gastroesophageal reflux disease diagnosed in general practice. Aliment Pharmacol Ther. 2004;20(7):751-760. https://doi.org/10.1111/j.1365-2036.2004.02169.x
Thompson WG, Heaton KW. Heartburn and globus in apparently people. Can Med Assoc J. 1982;126(1):46-48.
Teplukhina OYu, Maslovskii LV. Izuchenie kliniko-epidemiologicheskikh osobennostei gastroezofageal’noi reflyuksnoi bolezni, protekayushchei v sochetanii s drugimi gastroenterologicheskimi zabolevaniyami. Kremlevskaya meditsina. 2011;3:15-18. (In Russ.).
Jones R, Junghard 0, Dent J, et al. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther. 2009; 30:1030-38. https://doi.org/10.1111/j.1365-2036.2009.04142.x
U.S. Department of Agriculture/U.S. Department of Health and Human Services. Home and Garden Bulletin No. 232. Nutrition and Your Health: Dietary Guidelines for Americans. 3d ed. Washingt on, DC: Supt. of Docs., U.S. Govt. Print. Off., 1990. https://doi.org/10.1037/e566932010-001
VTsIOM: chislo kuril’shchikov v Rossii za poslednii god ne umen’shilos’. Accessed June, 23, 2017. Available at: http://tass.ru/obschestvo/2044307 (In Russ.).
Ozhirenie i izbytochnyi ves: Informatsionnyi byulleten’. June, 2016 Accessed June, 23, 2017. Available at: http://www.who.int/mediacentre/factsheets/fs311/ru/ (In Russ.).

Close metadata